Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03630991

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:19.212479+00:00

Published At

2026-03-02T00:00:00+00:00

Record Updated At

2026-03-02

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Acute Myeloid Leukemia", "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome", "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "High Risk Myelodysplastic Syndrome", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm", "Myeloproliferative Neoplasm", "Recurrent Acute Myeloid Leukemia", "Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Recurrent Myelodysplastic Syndrome", "Recurrent Myelodysplastic/Myeloproliferative Neoplasm", "Refractory Acute Myeloid Leukemia", "Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Refractory Myelodysplastic Syndrome", "Secondary Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndrome", "Very High Risk Myelodysplastic Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-02"

protocolSection.identificationModule.nctId

"NCT03630991"

protocolSection.identificationModule.officialTitle

"Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Therapy"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
• Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
• High Risk Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Myelodysplastic/Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)
• Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)
• Recurrent Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
• Recurrent Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Recurrent Myelodysplastic/Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)
• Refractory Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
• Refractory Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Secondary Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Secondary Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
• Very High Risk Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.